RNAZ TRANSCODE THERAPEUTICS INC Investments/Divestments 8-K Filing 2023 - Public Offering Transcode Therapeutics, Inc. entered into an underwriting agreement with ThinkEquity LLC for a public offering of 700,000 shares of common stock and pre-funded warrants, raising approximately $8.5 million.Get access to all SEC 8-K filings of the TRANSCODE THERAPEUTICS INC